Delivery Order SPE2DB22D2007-SPE2DB25FJ0AC
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 units of 40 mg Atorvastatin tablets, a cardiovascular medication, at a firm fixed price of $2,847.24. The contract has a completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award is for the delivery of 4,561,450,705 tablets of 80 mg Atorvastatin, a generic cardiovascular medication, to the Defense Logistics Agency (DLA). The $2,184.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 10, 2023, with a completion date of July 11, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,565,404,327 units of Atorvastatin 20 mg tablets. The contract, valued at $3,596.23, was awarded by the Defense Logistics Agency (DLA) on August 9, 2024, with a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a $1,584.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,651,931 units of Atorvastatin 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.07 firm fixed-price delivery order is for the supply of 4,561,290 units of Atorvastatin 10 mg tablets, a cardiovascular medication, with a completion date of June 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $1,627.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,905.06 firm fixed price delivery order is for 4,562,470,723 units of the drug Atorvastatin 40 mg tablets. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award is for the delivery of 1,000 tablets of 40 mg Atorvastatin, a prescription medication used to treat high cholesterol and related cardiovascular conditions. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract has a ceiling value of $1,897.08 and a completion date of November 15, 2023. It is a firm-fixed-price delivery order...
This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...